Skip to main content
Andor Glaudemans
prof. dr.

I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.

Fetal dose minimization: ultra-low dose long axial field of view (LAFOV) PET/CT imaging of a pregnant patient
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document 10.1007/s00259-024-06861-0 document
J H van Snick, K P Koopmans, A W J M Glaudemans, G N Stormezand, O V Ivashchenko
Clinical Performance Comparison of a Long Versus a Short Axial Field-of-View PET/CT Using EARL-Compliant Reconstructions
Published in: Molecular Imaging and Biology
Access to document 10.1007/s11307-024-01939-5 document
PURPOSE: To ensure comparable PET/CT image quality between or within centres, clinical inter-system performance comparisons following European Association of Nuclear Medicine Research Ltd. (EARL) guidelines is required. In this work the performance of the long axial field-of-view Biograph Vision Quadra is compared to its predecessor, the short axial field-of-view Biograph Vision. PROCEDURES: To this aim, patients with suspected tumour lesions received a single weight-based (3 MBq/kg) 2-deoxy-2-[ 18F]fluoro-D-glucose injection and underwent routine clinical ( ∼ 15 min) scans on the Vision and 3-min scans on the Quadra in...
Mostafa Roya, Johannes H van Snick, Riemer H J A Slart, Walter Noordzij, Gilles N Stormezand, Antoon T M Willemsen, Ronald Boellaard, Andor W J M Glaudemans, Charalampos Tsoumpas, Joyce van Sluis
Towards molecular imaging-guided intervention theatres in oncology
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document 10.1007/s00259-023-06545-1 document
J Vonk, S Kruijff, R H J A Slart, W Szymanski, M J H Witjes, A W J M Glaudemans
Performance of [18F]FDG PET/CT in Diagnosing Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and a Bivariate Meta-Analysis
Published in: Diagnostics
Access to document 10.3390/diagnostics14151603 document
BACKGROUND: Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([ 18F]FDG PET/CT) has been suggested as a useful imaging method for diagnosing cyst infections in patients with autosomal dominant polycystic kidney disease (ADPKD). The aim of this article is to provide evidence-based data in this setting. METHODS: A systematic literature review (exploring several bibliographic databases) and a bivariate meta-analysis were carried out to calculate the pooled diagnostic performance of [ 18F]FDG PET/CT in diagnosing probable cyst infection in ADPKD. RESULTS: Ten studies (282 PET/CT scans and 249 patients) were included...
Giorgio Treglia, Domenico Albano, Alessio Rizzo, Antonio Bellasi, Andor W J M Glaudemans, Olivier Gheysens
Nuclear medicine practice for the assessment of cardiac sarcoidosis and amyloidosis: A survey endorsed by the EANM and EACVI
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document 10.1007/s00259-024-06727-5 document
Irene Gotuzzo, Riemer H J A Slart, Alessia Gimelli, Nabila Ashri, Constantinos Anagnostopoulos, Jan Bucerius, Ronny R Buechel, Oliver Gaemperli, Olivier Gheysens, Andor W J M Glaudemans, Gilbert Habib, Fabian Hyafil, Mark Lubberink, Antti Saraste, Tomaz Podlesnikar, Marc R Dweck, Paola A Erba